. 2019 Aug 19;29(8):1036–1043. doi: 10.1089/thy.2019.0133

Table 2.

Summary of Surgical Procedures, Anaplastic Thyroid Carcinoma Viability, Resected Tumor Histopathology, and Pretreatment Mutation Profile

	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6
Procedures	TT, central ND, bilateral ND, limited resection of esophageal muscularis	TT, central ND, right ND, en bloc resection of right RLN	TT, central ND, left ND, en bloc resection of left RLN, shave resection of trachea	TT, central ND, revision right ND, left ND, resection of dermal metastasis	TT, central ND, left level IV ND, and resection of occipital scalp lesion	TT, central ND
Resection of ATC	Complete	Complete	Complete	Complete	Complete	Complete
Residual (R) tumor classification	R1	R0	R1	R0	R0	R0
Resected ATC viability, %^a	50	5	<5	0	0	0
Additional component in resected tumor	PTC	PTC	PTC	PDTC, PTC	PTC	PTC
Pretreatment tumor mutations	BRAF^V600E, TP53^R175H, EGFR G322S, BRAF amplification^b	BRAF^V600E, TP53^Q331 a	BRAF^V600E, TP53^D208V, CDKN2A^pE88 a	BRAF^V600E	BRAF^V600E, ATM^I1986V, MCL1 duplication	BRAF^V600E

^{^a}

Indicated viability of the ATC component of the postneoadjuvant treatment resected primary thyroid tumor.

^{^b}

Detected in cell-free DNA.

ATC, anaplastic thyroid carcinoma; ND, neck dissection; PDTC, poorly-differentiated thyroid carcinoma; PTC, papillary thyroid carcinoma; RLN, recurrent laryngeal nerve; TT, total thyroidectomy.